ASK REDCHAT ANYTHING ABOUT DARE BIOSCIENCE INC.
Dare Bioscience Inc. (NASDAQ: DARE)
Listen to this Section
$1.91
-0.2750
(
-12.60% )
331.8K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| XACIATO (DARE-BV1)DetailsBacterial infection |
Approved |
| Ovaprene®DetailsContraceptive |
Phase 3 |
| Sildenafil Cream, 3.6%DetailsSexual desire disorder, Sexual dysfunction |
Phase 3 |
| DARE-VVA1 (Tamoxifen formulation)DetailsVulvovaginal Candidiasis |
Phase 2 |
| DARE-PDM1DetailsPrimary dysmenorrhea |
Phase 1 |
| DARE-PTB1DetailsPreterm birth |
Phase 1 |
Market Data
|
| Open |
$1.91 |
| Previous Close |
$2.18 |
| Volume |
331.8K |
| Market Cap |
$30.71M |
| Day Range |
$1.90 - $2.19 |
| 52 Week Range |
$1.27 - $9.19 |
| Shares Outstanding |
14.98M |
| Change % |
-12.60% |
| Net Change |
▼ -0.2750 |
| Insider Ownership |
-0.15% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2014 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-1,530,000.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-06-07 |
Sale |
-40000.00 |
Matz Gregory W |
| 2024-06-07 |
Sale |
-40000.00 |
Kelley Susan L. |
| 2024-06-07 |
Sale |
-40000.00 |
RASTETTER WILLIAM H |
| 2024-06-07 |
Sale |
-40000.00 |
Steele Robin Joan |
| 2024-06-07 |
Sale |
-40000.00 |
Grossman Jessica D. |
| 2024-03-14 |
Sale |
-290000.00 |
Haring-Layton MarDee |
| 2024-03-14 |
Sale |
-750000.00 |
JOHNSON SABRINA MARTUCCI |
| 2024-03-14 |
Sale |
-290000.00 |
Fair John A |